Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Bruker Corp’s stock clocked out at $40.2, down -0.45% from its previous closing price of $40.38. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 3.33 million shares were traded. BRKR stock price reached its highest trading level at $40.74 during the session, while it also had its lowest trading level at $39.19.
Ratios:
To gain a deeper understanding of BRKR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.81.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $72.
On December 10, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $66.UBS initiated its Neutral rating on December 10, 2024, with a $66 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 12 ’25 when Friend Cynthia M sold 3,535 shares for $32.25 per share. The transaction valued at 113,990 led to the insider holds 18,016 shares of the business.
CYNTHIA FRIEND bought 3,535 shares of BRKR for $113,990 on Sep 12 ’25. On Jun 06 ’25, another insider, LAUKIEN FRANK H, who serves as the PRESIDENT & CEO of the company, bought 2,608 shares for $38.36 each. As a result, the insider paid 100,043 and bolstered with 38,462,171 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 6099118592 and an Enterprise Value of 7860660224. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.77 while its Price-to-Book (P/B) ratio in mrq is 3.38. Its current Enterprise Value per Revenue stands at 2.286 whereas that against EBITDA is 14.12.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.19, which has changed by -0.33245164 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $64.64, while it has fallen to a 52-week low of $28.53. The 50-Day Moving Average of the stock is 15.61%, while the 200-Day Moving Average is calculated to be -0.11%.
Shares Statistics:
It appears that BRKR traded 3.86M shares on average per day over the past three months and 3245130 shares per day over the past ten days. A total of 151.72M shares are outstanding, with a floating share count of 102.94M. Insiders hold about 32.15% of the company’s shares, while institutions hold 82.21% stake in the company. Shares short for BRKR as of 1760486400 were 13347504 with a Short Ratio of 3.46, compared to 1757894400 on 12188058. Therefore, it implies a Short% of Shares Outstanding of 13347504 and a Short% of Float of 18.969999.
Dividends & Splits
With its trailing 12-month dividend rate of 0.2, BRKR has a forward annual dividend rate of 0.20. Against a Trailing Annual Dividend Yield of 0.004952947. The stock’s 5-year Average Dividend Yield is 0.31.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 10.0 analysts currently analyzing and rating the stock of Bruker Corp (BRKR).The consensus estimate for the next quarter is $0.46, with high estimates of $0.61 and low estimates of $0.34.
Analysts are recommending an EPS of between $1.9 and $1.86 for the fiscal current year, implying an average EPS of $1.88. EPS for the following year is $2.15, with 13.0 analysts recommending between $2.45 and $1.75.
Revenue Estimates
In. The current quarter, 8 analysts expect revenue to total $960.08M. It ranges from a high estimate of $966.5M to a low estimate of $952.51M. As of. The current estimate, Bruker Corp’s year-ago sales were $979.6MFor the next quarter, 8 analysts are estimating revenue of $806.8M. There is a high estimate of $828.43M for the next quarter, whereas the lowest estimate is $792.3M.
A total of 10 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.43B, while the lowest revenue estimate was $3.41B, resulting in an average revenue estimate of $3.42B. In the same quarter a year ago, actual revenue was $3.37BBased on 10 analysts’ estimates, the company’s revenue will be $3.47B in the next fiscal year. The high estimate is $3.51B and the low estimate is $3.43B.
